Kestra Medical Technologies (NASDAQ:KMTS) Earns Overweight Rating from Analysts at Wells Fargo & Company
Research analysts at Wells Fargo & Company started coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS – Get Free Report) in a report released on Monday, MarketBeat.com reports. The firm set an “overweight” rating and a $28.00 price target on the stock. Wells Fargo & Company‘s price target would suggest a potential upside of 13.91% […]
Research analysts at Wells Fargo & Company started coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS – Get Free Report) in a report released on Monday, MarketBeat.com reports. The firm set an “overweight” rating and a $28.00 price target on the stock. Wells Fargo & Company‘s price target would suggest a potential upside of 13.91% […]
